Rocket Pharmaceuticals Inc (RCKT)
13.98
-0.84
(-5.67%)
USD |
NASDAQ |
Nov 15, 16:00
14.06
+0.08
(+0.57%)
After-Hours: 20:00
Rocket Pharmaceuticals Total Assets (Quarterly): 393.69M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 393.69M |
| June 30, 2024 | 446.41M |
| March 31, 2024 | 499.44M |
| December 31, 2023 | 566.34M |
| September 30, 2023 | 598.76M |
| June 30, 2023 | 461.78M |
| March 31, 2023 | 514.76M |
| December 31, 2022 | 551.81M |
| September 30, 2022 | 417.26M |
| June 30, 2022 | 431.85M |
| March 31, 2022 | 460.15M |
| December 31, 2021 | 497.02M |
| September 30, 2021 | 530.24M |
| June 30, 2021 | 535.15M |
| March 31, 2021 | 576.48M |
| December 31, 2020 | 590.82M |
| September 30, 2020 | 335.50M |
| June 30, 2020 | 353.06M |
| March 31, 2020 | 372.75M |
| December 31, 2019 | 372.12M |
| September 30, 2019 | 299.91M |
| Date | Value |
|---|---|
| June 30, 2019 | 308.72M |
| March 31, 2019 | 242.14M |
| December 31, 2018 | 251.31M |
| September 30, 2018 | 194.98M |
| June 30, 2018 | 207.57M |
| March 31, 2018 | 217.16M |
| December 31, 2017 | 101.78M |
| September 30, 2017 | 104.66M |
| June 30, 2017 | 111.06M |
| March 31, 2017 | 117.92M |
| December 31, 2016 | 129.65M |
| September 30, 2016 | 140.14M |
| June 30, 2016 | 99.85M |
| March 31, 2016 | 104.21M |
| December 31, 2015 | 113.32M |
| September 30, 2015 | 120.12M |
| June 30, 2015 | 51.69M |
| March 31, 2015 | 55.53M |
| December 31, 2014 | 5.52M |
| September 30, 2014 | 8.498M |
| December 31, 2013 | 12.86M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
335.50M
Minimum
Sep 2020
598.76M
Maximum
Sep 2023
475.27M
Average
479.40M
Median
Total Assets (Quarterly) Benchmarks
| Apellis Pharmaceuticals Inc | 901.87M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 63.92M |
| Shareholders Equity (Quarterly) | 329.77M |